Neha Patil (Editor)

PF 05089771

Updated on
Edit
Like
Comment
Share on FacebookTweet on TwitterShare on LinkedInShare on Reddit
CAS Number
  
1235403-62-9

ChemSpider
  
29411106

ChEMBL
  
CHEMBL2325014

PubChem CID
  
46840946

UNII
  
25U4N985O2

PF-05089771

Legal status
  
US: Investigational New Drug

PF-05089771 is a selective, small-molecule Nav1.7 and Nav1.8 voltage-gated sodium channel blocker under development by Pfizer as a novel analgesic. As of June 2014, it has completed phase II clinical trials for wisdom tooth removal and primary erythromelalgia.

References

PF-05089771 Wikipedia
(Text) CC BY-SA